643
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Use and timing of surfactant administration: impact on neonatal outcomes in extremely low gestational age infants born in Canadian Neonatal Intensive Care Units

ORCID Icon, , , , , , , & show all
Pages 2862-2869 | Received 24 Apr 2017, Accepted 18 Jul 2017, Published online: 31 Jul 2017

References

  • Brouwer A, Groenendaal F, van Haastert IL, et al. Neurodevelopmental outcome of preterm infants with severe intraventricular hemorrhage and therapy for post-hemorrhagic ventricular dilatation. J Pediatr. 2008;152(5):648–654.
  • Radic JA, Vincer M, McNeely PD. Outcomes of intraventricular hemorrhage and posthemorrhagic hydrocephalus in a population-based cohort of very preterm infants born to residents of Nova Scotia from 1993 to 2010. J Neurosurg Pediatr. 2015;15(6):580–588.
  • Sarkar S, Bhagat I, Dechert R, et al. Severe intraventricular hemorrhage in preterm infants: comparison of risk factors and short-term neonatal morbidities between grade 3 and grade 4 intraventricular hemorrhage. Am J Perinatol. 2009;26(6):419–424.
  • Soul JS, Hammer PE, Tsuji M, et al. Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants. Pediatr Res. 2007;61(4):467–473.
  • Rojas-Reyes MX, Morley CJ, Soll RF. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2012;3(3):(CD000510).
  • Krause MF, Hoehn T. Timing of surfactant administration determines its physiologic response in a rabbit model of airway lavage. Biol Neonate. 2000;77(3):196–202.
  • Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants – 2013 update. Neonatology. 2013;103(4):353–368.
  • Morley CJ, Davis PG, Doyle LW, et al. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008;358(7):700–708.
  • SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network FN, Carlo WA, Walsh MC, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010;21(21):1970–1979.
  • Cowan F, Whitelaw A, Wertheim D, et al. Cerebral blood flow velocity changes after rapid administration of surfactant. Arch Dis Child. 1991;66(10 Spec No):1105–1109.
  • Horbar JD, Carpenter JH, Buzas J, et al., Vermont Oxford Network. Timing of initial surfactant treatment for infants 23 to 29 weeks’ gestation: is routine practice evidence based? Pediatrics. 2004;113(6):1593–1602.
  • Stevens TP, Harrington EW, Blennow M, et al. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev. 2007;4:CD003063.
  • Hellström-Westas L, Bell AH, Skov L, et al. Cerebroelectrical depression following surfactant treatment in preterm neonates. Pediatrics. 1992;89(4 Pt 1):643–647.
  • Kaiser JR, Gauss CH, Williams DK. Surfactant administration acutely affects cerebral and systemic hemodynamics and gas exchange in very-low-birth-weight infants. J Pediatr. 2004;144(6):809–814.
  • Shah PS, Seidlitz W, Chan P, et al. Internal audit of the Canadian neonatal network data collection system. Am J Perinatol. 2017. doi:10.1055/s-0037-1603325.
  • Papile LA, Burstein J, Burstein R, et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529–534.
  • Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1–7.
  • Shennan AT, Dunn MS, Ohlsson A, et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82(4):527–532.
  • International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991–999.
  • Davis DJ, Barrington K, Canadian Paediatric Society Fetus and Newborn Committee. Recommendations for neonatal surfactant therapy. Paediatr Child Health. 2005;10(2):109–116.
  • Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2001;2(2):CD000510.
  • Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11:CD001456.
  • Celebi AR, Petricli IS, Hekimoglu E, et al. The incidence and risk factors of severe retinopathy of prematurity in extremely low birth weight infants in Turkey. Med Sci Monit. 2014;20:1647–1653.
  • Horbar JD, Carpenter JH, Buzas J, et al. Collaborative quality improvement to promote evidence based surfactant for preterm infants: a cluster randomised controlled trial. BMJ. 2004;329(7473):1004.
  • Klebermass-Schrehof K, Wald M, Schwindt J, et al. Less invasive surfactant administration in extremely preterm infants: impact on mortality and morbidity. Neonatology. 2013;103(4):252–258.
  • Premnath D, Kent AL, Bajuk B, et al. Does timing of initial surfactant treatment make a difference in rates of chronic lung disease or mortality in premature infants? An observational regional study. J Matern Fetal Neonatal Med. 2016;29(1):91–98.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.